Edited by humans. Written by AI. How our editing works

Pig Kidney Xenotransplant

What's Breaking Through

Breakthrough in transplanting gene-edited pig kidneys into human patients with end-stage kidney disease.

tracking 5 signals

About this topic

A major milestone in organ transplantation has been achieved through xenotransplantation, the practice of transplanting organs from one species to another. Researchers successfully implanted a genetically modified pig kidney into a living human patient, where it functioned for approximately nine months before the patient received a traditional human kidney transplant. This represents a world first and a significant step forward in addressing the critical shortage of available donor organs for patients with end-stage kidney disease.

The pig kidney used in this procedure was not from an ordinary pig but rather a specially gene-edited animal designed to prevent rejection by the human immune system. Multiple genes in the pig were modified to reduce the likelihood of xenogeneic rejection, a major biological barrier that has historically limited cross-species transplantation. The successful nine-month period demonstrates that these genetic modifications can provide meaningful immunological tolerance, at least in the medium term. During its time in the patient's body, the pig kidney performed essential filtration functions, effectively keeping the recipient off dialysis—a time-consuming treatment that many end-stage kidney disease patients must undergo multiple times weekly.

This achievement is particularly significant because it shows a pathway forward for organ shortage solutions. Rather than serving as a permanent replacement, the xenotransplant in this case functioned as a bridge, sustaining the patient until a human donor organ became available. Once the human kidney was transplanted, the pig kidney was removed. This bridging strategy may prove especially valuable for patients on waiting lists, as it can improve their health outcomes while they await traditional transplants. The success of this case has opened doors for further research into xenotransplantation as a viable therapeutic option, potentially transforming treatment possibilities for thousands of patients suffering from organ failure worldwide.

5 signals from source feeds

These are external articles in the Science desk that match this topic. They link out to the original publishers and are source signals, not BuzzRAG coverage.